{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-21T05:45:08.753915+00:00","published_at":"2026-10-21T04:48:59.447603+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:443c1p157mcn1","event_type":"CFO_CHANGED","effective_at":"2026-03-31","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:andrew-sims","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:7db370acb3f9edf395d211e13878566ea0d4afdae71f3d8be3979cb6a84a03d3"],"summary":"Andrew Sims executive of PLUS THERAPEUTICS, INC., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1erdft218svet0","event_type":"CEO_CHANGED","effective_at":"2026-03-31","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:marc-h-hedrick-m-d","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:9e1bfa997e17a7223f1c8b883c7fb8923227a061a717ad974749ec626efefd26"],"summary":"Marc H. Hedrick, M.D. executive of PLUS THERAPEUTICS, INC., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:uo0ikn12c95er","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-31","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:norman-lafrance-m-d","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:2e0d8114d132142ae328cf5ccee005f836eae1f0f6a97e34b71a200ac33f23dd"],"summary":"Norman LaFrance, M.D. executive of PLUS THERAPEUTICS, INC., effective 2026-03-31.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ty23mfoysw2h","event_type":"DIRECTOR_APPOINTED","effective_at":"2026-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:ronald-a-andrews","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Ronald A. Andrews seat on PLUS THERAPEUTICS, INC., effective 2026-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:b6vbko5mkaao","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:kyle-guse-esq-mba-cpa","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Kyle Carver, M.B.A., C.P.A. seat on PLUS THERAPEUTICS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:y6o4n41v898sg","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:committee:plus-therapeutics-inc:audit-chair-compensation","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Audit · Chair; Compensation committee of PLUS THERAPEUTICS, INC., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:104gxz6lmqu9g","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:kyle-guse-esq-mba-cpa","alpha:committee:plus-therapeutics-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Kyle Carver, M.B.A., C.P.A. member of Audit · Chair; Compensation, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yare3jvv3kbj","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:an-van-es-johansson-m-d","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"An van Es-Johansson, M.D. seat on PLUS THERAPEUTICS, INC., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:k4amgikhzp00","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:howard-clowes","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Howard Clowes seat on PLUS THERAPEUTICS, INC., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:w76o462antw0","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:committee:plus-therapeutics-inc:audit-compensation-nominating-and-governance-chair","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Audit; Compensation; Nominating and Governance · Chair committee of PLUS THERAPEUTICS, INC., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cwmjwayd24ka","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:howard-clowes","alpha:committee:plus-therapeutics-inc:audit-compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Howard Clowes member of Audit; Compensation; Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:atxwsyx5lo06","event_type":"DIRECTOR_APPOINTED","effective_at":"2007-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:richard-j-hawkins","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Richard J. Hawkins seat on PLUS THERAPEUTICS, INC., effective 2007-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jf3zewimtrkg","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2007-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:richard-j-hawkins","alpha:committee:plus-therapeutics-inc:nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_record:20"],"evidence_ids":["alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea"],"summary":"Richard J. Hawkins member of Nominating and Governance, effective 2007-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:xc28pe14q14pm","event_type":"DIRECTOR_APPOINTED","effective_at":"2002-01-01","detected_at":"2026-10-21T04:48:59.447603+00:00","subject_ids":["alpha:person:marc-h-hedrick-m-d","alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be"],"caused_claim_ids":["alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f"],"summary":"Marc H. Hedrick, M.D. seat on PLUS THERAPEUTICS, INC., effective 2002-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:5","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:an-van-es-johansson-m-d","object_label":"An van Es-Johansson, M.D.","object_source_name_forms":[],"value":"An van Es-Johansson, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:an-van-es-johansson-m-d","name":"An van Es-Johansson, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PLUS THERAPEUTICS, INC. DEF 14A 2026-03-31","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31","retrieved_at":"2026-04-25T00:00:03.412+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:6","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:howard-clowes","object_label":"Howard Clowes","object_source_name_forms":[],"value":"Howard Clowes: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:howard-clowes","name":"Howard Clowes"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PLUS THERAPEUTICS, INC. DEF 14A 2026-03-31","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31","retrieved_at":"2026-04-25T00:00:03.412+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:7","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kyle-guse-esq-mba-cpa","object_label":"Kyle Carver, M.B.A., C.P.A.","object_source_name_forms":[],"value":"Kyle Carver, M.B.A., C.P.A.: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kyle-guse-esq-mba-cpa","name":"Kyle Carver, M.B.A., C.P.A."},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PLUS THERAPEUTICS, INC. DEF 14A 2026-03-31","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31","retrieved_at":"2026-04-25T00:00:03.412+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:8","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:marc-h-hedrick-m-d","object_label":"Marc H. Hedrick, M.D.","object_source_name_forms":[],"value":"Marc H. Hedrick, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:marc-h-hedrick-m-d","name":"Marc H. Hedrick, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2002-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2002-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PLUS THERAPEUTICS, INC. DEF 14A 2026-03-31","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31","retrieved_at":"2026-04-25T00:00:03.412+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31","effective_from":"2002-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:9","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-j-hawkins","object_label":"Richard J. Hawkins","object_source_name_forms":[],"value":"Richard J. Hawkins: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-j-hawkins","name":"Richard J. Hawkins"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2007-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2007-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PLUS THERAPEUTICS, INC. DEF 14A 2026-03-31","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31","retrieved_at":"2026-04-25T00:00:03.412+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31","effective_from":"2007-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:10","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ronald-a-andrews","object_label":"Ronald A. Andrews","object_source_name_forms":[],"value":"Ronald A. Andrews: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ronald-a-andrews","name":"Ronald A. Andrews"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2026-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-01-01","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PLUS THERAPEUTICS, INC. DEF 14A 2026-03-31","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31","retrieved_at":"2026-04-25T00:00:03.412+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31","effective_from":"2026-01-01","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:11","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:andrew-sims","object_label":"Andrew Sims","object_source_name_forms":[],"value":"Andrew Sims: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:andrew-sims","name":"Andrew Sims"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:7db370acb3f9edf395d211e13878566ea0d4afdae71f3d8be3979cb6a84a03d3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PSTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T07:14:35.392375+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:12","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:marc-h-hedrick-m-d","object_label":"Marc H. Hedrick, M.D.","object_source_name_forms":[],"value":"Marc H. Hedrick, M.D.: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:marc-h-hedrick-m-d","name":"Marc H. Hedrick, M.D."},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:9e1bfa997e17a7223f1c8b883c7fb8923227a061a717ad974749ec626efefd26","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PSTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T07:14:34.925663+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:leadership_role:13","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:norman-lafrance-m-d","object_label":"Norman LaFrance, M.D.","object_source_name_forms":[],"value":"Norman LaFrance, M.D.: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:norman-lafrance-m-d","name":"Norman LaFrance, M.D."},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-31","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-31","valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:document:2e0d8114d132142ae328cf5ccee005f836eae1f0f6a97e34b71a200ac33f23dd","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PSTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T07:14:35.83576+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-31T00:00:00+00:00","effective_from":"2026-03-31","effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be:committee_record:20","subject_id":"alpha:company:5f98d006-4797-4b5b-8ccb-f88196b3b3be","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Howard Clowes; Members Howard Clowes (Chair); Richard J. Hawkins; Ronald A. Andrews","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Howard Clowes","members":[{"display_name":"Howard Clowes","person_slug":"howard-clowes","is_chair":true},{"display_name":"Richard J. Hawkins","person_slug":"richard-j-hawkins","is_chair":false},{"display_name":"Ronald A. Andrews","person_slug":"ronald-a-andrews","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-21T04:48:59.447603+00:00","sources":[{"id":"alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:f2b02ec61a4ee61f346e60ababa607ae17872bfb0a9a4a686290a8e2ba5fac5f","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"PLUS THERAPEUTICS, INC. DEF 14A 2026-03-31","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31","retrieved_at":"2026-04-25T00:00:03.412+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:7db370acb3f9edf395d211e13878566ea0d4afdae71f3d8be3979cb6a84a03d3","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PSTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T07:14:35.392375+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9e1bfa997e17a7223f1c8b883c7fb8923227a061a717ad974749ec626efefd26","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PSTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T07:14:34.925663+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:2e0d8114d132142ae328cf5ccee005f836eae1f0f6a97e34b71a200ac33f23dd","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PSTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":"2026-03-31T00:00:00+00:00","retrieved_at":"2026-05-16T07:14:35.83576+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:6bac83f1723b5914be57f8a36a8c8c9eb816fad30ed1b5c9261518d65b2ab8ea","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526134646/pstv-20260331.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.836,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.887,"cross_source_agreement":0.75,"temporal_completeness":0.563},"diagnostics":{"published_claims":23,"factual_claims":23,"claims_with_linked_evidence":23,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":16,"temporal_claims_with_valid_from":9,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-21T04:48:59.447603+00:00","observed_at":"2026-10-21T04:48:59.447603+00:00","reviewed_at":"2026-10-21T04:48:59.447603+00:00","verified_at":"2026-10-21T04:48:59.447603+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/plus-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/plus-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}